OLMA · Company research
Olema Pharmaceuticals, Inc. Common Stock (OLMA): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Price-Driven Insight from (OLMA) for Rule-Based Strategy - Stock Traders Daily | Price-Driven Insight from (OLMA) for Rule-Based Strategy Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 18, 2026 | neutral | 0 | 0.6 |
| A 9.99% ownership cap limits warrant exercises at Olema Pharmaceuticals (OLMA). - Stock Titan | A 9.99% ownership cap limits warrant exercises at Olema Pharmaceuticals (OLMA). Stock Titan | View source ↗ | Stock Titan | Oct 16, 2026 | neutral | 0 | 0.6 |
| Olema Pharmaceuticals, Inc. (OLMA) Latest Stock News & Headlines - Yahoo! Finance Canada | Olema Pharmaceuticals, Inc. (OLMA) Latest Stock News & Headlines Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 16, 2026 | neutral | 0 | 0.6 |
| Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Stock Has Consensus Price Target of $40.60 According to Brokerages - MarketBeat | Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Stock Has Consensus Price Target of $40.60 According to Brokerages MarketBeat | View source ↗ | MarketBeat | Oct 14, 2026 | neutral | 0 | 0.6 |
| Understanding the Setup: (OLMA) and Scalable Risk - Stock Traders Daily | Understanding the Setup: (OLMA) and Scalable Risk Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 8, 2026 | neutral | 0 | 0.6 |
| Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Up 3.4% - Here's Why - MarketBeat | Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Up 3.4% - Here's Why MarketBeat | View source ↗ | MarketBeat | Oct 7, 2026 | neutral | 0 | 0.6 |
| OLMA News | OLEMA PHARMACEUTICALS INC (NASDAQ:OLMA) - ChartMill | OLMA News | OLEMA PHARMACEUTICALS INC (NASDAQ:OLMA) ChartMill | View source ↗ | ChartMill | Sep 25, 2026 | neutral | 0 | 0.6 |
| A new finance chief gets options on 650,000 Olema shares - Stock Titan | A new finance chief gets options on 650,000 Olema shares Stock Titan | View source ↗ | Stock Titan | Sep 2, 2026 | neutral | 0 | 0.6 |
| $OLMA stock is down 12% today. Here's what we see in our data. - Quiver Quantitative | $OLMA stock is down 12% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 11, 2026 | neutral | 0 | 0.6 |
| Olema Pharmaceuticals Stock Falls as Pivotal Breast Cancer Data Pushed Into 2027 - Benzinga | Olema Pharmaceuticals Stock Falls as Pivotal Breast Cancer Data Pushed Into 2027 Benzinga | View source ↗ | Benzinga | Aug 11, 2026 | neutral | 0 | 0.6 |
| Olema Pharmaceuticals (OLMA) Is Up 22.0% After Broad Russell Growth Index Inclusion - Has The Bull Case Changed? - Simply Wall Street | Olema Pharmaceuticals (OLMA) Is Up 22.0% After Broad Russell Growth Index Inclusion - Has The Bull Case Changed? Simply Wall Street | View source ↗ | Simply Wall Street | Jun 30, 2026 | neutral | 0 | 0.6 |
| OLMA Forecast — Price Target — Prediction for 2027 - TradingView | OLMA Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| OLMA Sees Early Tumor Shrinkage in Phase 1 OP-3136 Study, Stock Gains Pre-Market - Stocktwits | OLMA Sees Early Tumor Shrinkage in Phase 1 OP-3136 Study, Stock Gains Pre-Market Stocktwits | View source ↗ | Stocktwits | May 22, 2026 | neutral | 0 | 0.6 |
| Olema: The Market Overreacted To Roche's SERD Failure - Seeking Alpha | Olema: The Market Overreacted To Roche's SERD Failure Seeking Alpha | View source ↗ | Seeking Alpha | May 15, 2026 | neutral | 0 | 0.6 |
| Olema Pharmaceuticals (OLMA) Loses 33.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance | Olema Pharmaceuticals (OLMA) Loses 33.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Yahoo Finance | View source ↗ | Yahoo Finance | Mar 18, 2026 | neutral | 0 | 0.6 |
| Should I buy Olema Pharmaceuticals (OLMA) - Zacks Investment Research | Should I buy Olema Pharmaceuticals (OLMA) Zacks Investment Research | View source ↗ | Zacks Investment Research | Mar 18, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.